Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | |
| Sales | 130 |
| Cost of Goods | 210 |
| Gross Profit | -70 |
| Operating Expenses | 7,780 |
| Operating Income | -7,650 |
| Other Income | 60 |
| Pre-tax Income | -7,590 |
| Income Tax | -11,730 |
| Net Income Continuous | -19,331 |
| Net Income | $-19,330 |
| EPS Basic Total Ops | -788.48 |
| EPS Basic Continuous Ops | -789.02 |
| EPS Diluted Total Ops | -788.48 |
| EPS Diluted Continuous Ops | -789.02 |
| EBITDA(a) | $-7,460 |